New Wave Biotech Ltd
Private Limited Company · Manchester
ActiveUnited KingdomIncorporated 2022Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 43 source facts · 14 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 43 source facts · 14 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 18
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod223_4310_14555913_20251231
- Source archive
- Accounts_Bulk_Data-2026-09-18.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-12-31
IXBRL · 43 source facts · 14 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 43 source facts · 14 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 18
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2507_14555913_20241231
- Source archive
- Accounts_Monthly_Data-July2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 48 source facts · 9 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 48 source facts · 9 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 17
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2022-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1766_14555913_20231231
- Source archive
- Accounts_Monthly_Data-February2024.zip
Registered details
14555913- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2022-12-23
- Jurisdiction
- —
- Registered office
- INTERNATIONAL HOUSE, 61 MOSLEY STREET, MANCHESTER, M2 3HZ, ENGLAND
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsCommercialising Bioprocess Foresight across UK advanced manufacturing frontier industriesLeadLive
Innovate UK · Grant for R&D · 2026-08-01 – 2027-04-30
£69,880
awarded
Optimisation of downstream processing of lipids using solvent and non-solvent based extraction for technical output, economic and sustainability through AI-powered in-silico experimentationLeadInnovate UK · Collaborative R&D · 2025-08-01 – 2026-07-31 · with 1 other participant£122,499awarded
Optimisation of downstream processing of lipids using solvent and non-solvent based extraction for technical output, economic and sustainability through AI-powered in-silico experimentationLead
Innovate UK · Collaborative R&D · 2025-08-01 – 2026-07-31 · with 1 other participant
£122,499
awarded
New Wave Biotech Ltdlead£122,499
Development of innovative food products using plant proteins and precision fermentation with in-silico optimisationLeadInnovate UK · CR&D Bilateral · 2024-10-01 – 2026-03-31 · with 1 other participant£405,481awarded
Development of innovative food products using plant proteins and precision fermentation with in-silico optimisationLead
Innovate UK · CR&D Bilateral · 2024-10-01 – 2026-03-31 · with 1 other participant
£405,481
awarded
New Wave Biotech Ltdlead£405,481
Biomanufacturing downstream process optimisation and scaling with in-silico experimentationLeadInnovate UK · Collaborative R&D · 2023-12-01 – 2024-12-31 · with 1 other participant£155,342awarded
Biomanufacturing downstream process optimisation and scaling with in-silico experimentationLead
Innovate UK · Collaborative R&D · 2023-12-01 – 2024-12-31 · with 1 other participant
£155,342
awarded
New Wave Biotech Ltdlead£155,342
Automated Technoeconomic Analysis for Biomanufacturing OptimisationLead
Innovate UK · Grant for R&D · 2023-06-01 – 2023-10-31
£49,862
awarded